HAVCR2 and experimental autoimmune encephalomyelitis: Anti-TIM-3 blocking murine model develops hyper-acute experimental autoimmune encephalomyelitis (EAE) (77); treatment with soluble TIM-3-Ig results in T-cell hyper-activation and IFN-γ production (81).